1. Introduction
2. Summary of the experiment
3. Results
4. Materials and methods
4-1. Construction
4-2 Assay Protocol
5. Reference
|
|
|
1. Introduction |
|
In the modeling (Fig. 3-1-1-1.), the better interdependence between Company and Customer requires that the expression of LasI under the control of Prhl promoter (BBa_R0071) is the same level as the expression of RhlI under the control of Plux promoter (BBa_R0062). Thus, we firstly tested the expression level of Prhl promoter and Plux promoter through the reporter assay (Fig. 3-1-1-2.). |
Fig. 3-1-1-1. The phase diagram of Plux and Prhl intensity |
Fig. 3-1-1-2. Plux and Prhl Reporter Assay flow chart |
|
|
|
2. Summary of the experiment |
|
Our purpose is to confirm the expression level of Prhl promoter (BBa_R0071) and Plux promoter (BBa_R0062). We prepared two plasmids sets shown in below (Fig. 3-1-2-1.). We measured fluorescence intensity by GFP expression when we added signaling molecules.
We prepared four conditions shown in below.
A-1: Culture containing Ptet-LuxR and Plux-GFP cell with 3OC12HSL
A-2: Culture containing Ptet-LuxR and Plux-GFP cell with DMSO
B-1: Culture containing Ptet-RhlR and Prhl-GFP cell with C4HSL
B-2: Culture containing Ptet-RhlR and Prhl-GFP cell with DMSO
|
|
Fig. 3-1-2-1. Reporter plasmids
|
|
|
|
3. Results |
|
|
Fig. 3-1-3-1. Plux and Prhl Reporter Assay result |
|
From the modeling results, it showed that the expression level of the pre-existing BioBrick Prhl promoter (BBa_R0071) was too weak to satisfy our requirement (Fig. 3-1-3-1 lane 2). In other words, the expression of RhlI under the control of Plux promoter (BBa_R0062) was higher than the expression of LasI under the control of Prhl promoter.
|
|
|
|
4. Materials and methods |
|
4-1. Construction |
|
All the samples were JM2.300 strain
|
-Plasmids |
A. Ptet-LuxR (pSB6A1), Plux-GFP (pSB3K3) |
|
Fig. 3-1-4-1.
|
B. Ptet-RhlR (pSB6A1), Prhl-GFP (pSB3K3)
|
|
|
|
|
4-2. Assay Protocol
|
- 1.Prepare 2 overnight cultures for each sample in 3 mL LB medium, containing ampicillin (50 microg / mL) and kanamycin (30 microg / mL) at 37°C for 12 h.
-
2.Dilute the overnight cultures to 1 / 100 in fresh LB medium (3 mL) containing ampicillin (50 microg / mL) and kanamycin (30 microg / mL) (fresh culture).
-
3.Incubate the fresh cultures in 37°C until the OD590 reaches 0.3.
- Add 30 microL of 500 microM C4HSL, 500 nM 3OC12HSL or DMSO as listed below:
A-1: A + 500 nM 3OC12HSL
A-2: A + DMSO
B-1: B +500 microM C4HSL
B-2: B + DMSO
-
5. Incubate the samples at 37°C for 4 h.
-
6. Start preparing the flow cytometer 1 h before the end of incubation.
-
7.Take 200 microL of the sample, and centrifuge at 9000x g, 1 min, 4°C.
-
8. Remove the supernatant by using P1000 pipette.
-
9. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend.
- 10. Dispense all of each suspension into a disposable tube through a cell strainer.
11. Measure fluorescence intensity with a flow cytometer (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company).
|
|
|
|
5. Reference |
|
1. 1. Kendall M. Gray et al. (1994) Interchangeability and specificity of components from the quorum-sensing regulatory systems of Vibrio fischeri and Pseudomonas aeruginosa. Journal of Bacteriology 176(10): 3076–3080
|
|